Share >  
Share
Share on Tumblr

Sujay Shetty

News »

   latest by relevance
Tug of war for Parkway Holdings: What will Fortis do next?
May 29, 2010 at 11:27 | Source: CNBC-TV18
Parkway Holdings is in the middle of what could potentially become a big bidding war. Both Fortis and Malaysia's Khazanah are very interested in the Singapore-based healthcare company. In an interview with CNBC-TV18, Hitesh Sharma of E&Y and Sujay Shetty of PwC discussed the interesting merger and acquisition (M&A) situation building up.
Growth formula: Experts analyse the Abbott-Piramal deal
May 21, 2010 at 20:56 | Source: CNBC-TV18
Abbott laboratories will buy Piramal Healthcare's domestic formulations business for a whopping USD 3.7 billion. In an interview with CNBC-TV18, Sujay Shetty, Leader - Pharma (India), PwC and Vikas Dandekar of Pharmasianews.com, gave their perspectives on the deal.
Analysing pharma: Classroom gyan on API, CRAM & FDA
Aug 29, 2009 at 13:25 | Source: CNBC-TV18
Pharmaceuticals has been lying low for a long time but it is a major constituent in the stock market and perhaps it is time to understand better what exactly it is that drives this industry and what the various moving parts of it might be.
Big pharma deals inevitable as revenues dry up: PWC India
Mar 09, 2009 at 21:14 | Source: CNBC-TV18
Commenting on the development and various acquisitions and deals in the pharmaceutical world, Sujay Shetty, Associate Director - Pharmaceutical & Life Sciences, PWC India, said such deals were now inevitable as revenues dry up
Will Pfizer benefit with Wyeth merger? Experts discuss
Jan 24, 2009 at 16:20 | Source: CNBC-TV18
Sujay Shetty believes this merger would spark off a wave of consolidation global. However, Brian Tempest sees a risk to this merger. He said that Pfizer would spend a lot of money in carrying out this transaction but history shows that many of these mergers that have taken place were unable to improve the product pipeline
Experts see boom in pharma outsourcing due to eco crisis
Nov 11, 2008 at 09:11 | Source: CNBC-TV18
A little under 10% of the Indian pharma industry thrives on outsourcing. But experts believe this segment is in for some robust growth, thanks to the global economic slowdown. Sriram Iyer and Vivin Mathew find out that global companies are eyeing India as a destination for outsourcing of manufacturing and research and development.

Videos »
Tug of war for Parkway Holdings: What will Fortis do next?
Growth formula: Experts analyse the Abbott-Piramal deal
Analysing pharma: Classroom gyan on API, CRAM & FDA
Big pharma deals inevitable as revenues dry up: PWC India
Will Pfizer benefit with Wyeth merger? Experts discuss
more »

Photos »

  /  
Related News »
Dubai: Bellary Bishop, Kemaru Swami, Accorded Warm Welcome
Vishwanath Shetty, entertainment secretary, Sujay Bendur, Jeevan Kukian, and others. Karnataka Sangha's 10th anniversary will include presentation of ‘Mayura Awards’ to three achievers from different fields. The event will also have top class ...
May 17, 2012 at 09:04 | Source: daijiworld.com

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window